Skip to main content

Molecularly Targeted Anti-Cancer Therapies

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    axitinib
    bicalutamide
    crizoatinib
    dasatinib
    erlotinib HCL
    everolimus
    gefitinib
    imatinib mesylate
    lapatinib ditosylate
    nilotinib HCL
    pazopanib HCL
    ruxolitinib phosphate
    sorafenib tosylate
    sunitinib malate
    tamoxifen citrate
    vandetanib
    vemurafenib
    vismodegib
    Description

    These reports look at the use of 18 selected generic drug products relating to molecularly targeted anti-cancer therapies in the Mini-Sentinel Distributed Database (MSDD). These results were generated using the Mini-Sentinel Distributed Query Tool. This query was run against the Dispensing Summary Table and distributed on May 10, 2013 to 17 Data Partners; this report includes information from 17 Data Partners. 

    Additional Details
    FDA Center
    CDER
    Time Period
    2000 - 2012
    Analysis Type
    Summary Table
    Population / Cohort
    All individuals
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)